In our study, we attempted to adapt SDSPAGE into a reliable and easy-to-use method that can be performed in any dialysis unit to assess total amounts of middle weight molecules removed during a complete dialysis session

In our study, we attempted to adapt SDSPAGE into a reliable and easy-to-use method that can be performed in any dialysis unit to assess total amounts of middle weight molecules removed during a complete dialysis session. To make this method easier, we adopted Coomassie Complanatoside A blue staining of the gels. 2022.5, 2330 and 6080 kDa molecular weight) and showed clear differences in the amounts of removed proteins between the dialysers, particularly in the 2022.5, 2330 and 6080 kDa ranges. Total mass of eliminated 2m, RBP and albumin were Complanatoside A in agreement with SDSPAGE, while serum assays showed differing results. Conclusions.SDSPAGE scanning provided a good characterization of protein patterns in the spent dialysate; it prolonged and agreed with protein determinations and allowed a better assessment of dialyser overall performance in eliminating 10 to 80 kDa molecular excess weight substances. It also recognized variations between the three primarily filtrating polysulfone dialysers that were not recognized with blood measurements. Keywords:haemodialysis, middle molecules, protein removal into dialysate, SDSPAGE, spent dialysate == Intro == Urea levels possess classically been used like a marker of dialysis adequacy [1]. However, there is an impressive list of solutes that potentially contribute to uraemic toxicity [2], and this list is still growing [3]. Evidence for participation of these newly recognized culprits in the development of uraemic syndrome and their association with morbidity and mortality offers directed attention to additional markers in the 8 to 60 kDa molecular excess weight range that may help to assess dialysis adequacy [4]. Molecules that are hard to remove by dialysis, such as these larger middle molecular excess weight compounds and protein-bound molecules, play a significant part in uraemic toxicity [5]. Dialysis manufacturers have developed fresh dialysers having improved geometry and fresh membranes that enhance removal of middle molecular excess weight molecules with the aim of improving clinical results [6,7]. However, there are presently no accepted methods that allow easy and exact measurement of removal capacities of uraemic retention solutes in the 8 to 60 kDa molecular excess weight range by these fresh generation dialysers. To evaluate dialyser overall Complanatoside A performance, most authors identified variations in blood levels of particular proteins [8]; however, the majority of manufacturers limit information about dialyser overall performance to variations in blood levels Complanatoside A of beta 2 microglobulin (2m) which represents quite a restraint amount of info [4]. SDSPAGE, which was 1st proposed by Laemmli in 1970 [9], is a reliable method for protein characterization that is easy to use and has been rendered widely available in the medical setting. The aim of the present study was to Complanatoside A assess the usefulness of scanning SDSPAGE profiles of proteins contained in spent dialysate to evaluate the removal capacities of the new generation high-flux polysulfone dialysersin vivoduring routine medical haemodialysis. == Materials and methods == == Individuals == Eighteen stable dialysis individuals treated in the dialysis centre at Nphrologie Dialyse St Guilhem in Ste were included in the study. They were dialysed three times a week with fully equipped AK200S machines (Gambro, Lund, Sweden) using ultrapure double reverse osmosis water and a measured dialysate circulation of 500 10 mL/min. They had been on dialysis for more than 3 months and experienced no active disease at the time of testing. The study was explained to the patients SF1 and they offered knowledgeable consent to participate in the protocol. This study was authorized by the Comit de Safety des Personnes of Nmes (2009.01.07 bis) and was given a registration quantity in the French Agency AFSSAPS 2008-A01612-53. == Study design == A schematic of the study design is given inFigure 1. Three fresh generation polysulfone dialysers were assessed..